Identification of common differentially expressed genes in urinary bladder cancer.

<h4>Background</h4>Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the utilization of microarrays.<h4>Purpose</h4>Our goal was to identify common differentially expressed (DE) genes among clinically relevant subclasses of BC using...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Apostolos Zaravinos, George I Lambrou, Ioannis Boulalas, Dimitris Delakas, Demetrios A Spandidos
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cded9b131f7341ea82571a9e149b8786
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cded9b131f7341ea82571a9e149b8786
record_format dspace
spelling oai:doaj.org-article:cded9b131f7341ea82571a9e149b87862021-11-18T06:56:16ZIdentification of common differentially expressed genes in urinary bladder cancer.1932-620310.1371/journal.pone.0018135https://doaj.org/article/cded9b131f7341ea82571a9e149b87862011-04-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21483740/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the utilization of microarrays.<h4>Purpose</h4>Our goal was to identify common differentially expressed (DE) genes among clinically relevant subclasses of BC using microarrays.<h4>Methodology/principal findings</h4>BC samples and controls, both experimental and publicly available datasets, were analyzed by whole genome microarrays. We grouped the samples according to their histology and defined the DE genes in each sample individually, as well as in each tumor group. A dual analysis strategy was followed. First, experimental samples were analyzed and conclusions were formulated; and second, experimental sets were combined with publicly available microarray datasets and were further analyzed in search of common DE genes. The experimental dataset identified 831 genes that were DE in all tumor samples, simultaneously. Moreover, 33 genes were up-regulated and 85 genes were down-regulated in all 10 BC samples compared to the 5 normal tissues, simultaneously. Hierarchical clustering partitioned tumor groups in accordance to their histology. K-means clustering of all genes and all samples, as well as clustering of tumor groups, presented 49 clusters. K-means clustering of common DE genes in all samples revealed 24 clusters. Genes manifested various differential patterns of expression, based on PCA. YY1 and NFκB were among the most common transcription factors that regulated the expression of the identified DE genes. Chromosome 1 contained 32 DE genes, followed by chromosomes 2 and 11, which contained 25 and 23 DE genes, respectively. Chromosome 21 had the least number of DE genes. GO analysis revealed the prevalence of transport and binding genes in the common down-regulated DE genes; the prevalence of RNA metabolism and processing genes in the up-regulated DE genes; as well as the prevalence of genes responsible for cell communication and signal transduction in the DE genes that were down-regulated in T1-Grade III tumors and up-regulated in T2/T3-Grade III tumors. Combination of samples from all microarray platforms revealed 17 common DE genes, (BMP4, CRYGD, DBH, GJB1, KRT83, MPZ, NHLH1, TACR3, ACTC1, MFAP4, SPARCL1, TAGLN, TPM2, CDC20, LHCGR, TM9SF1 and HCCS) 4 of which participate in numerous pathways.<h4>Conclusions/significance</h4>The identification of the common DE genes among BC samples of different histology can provide further insight into the discovery of new putative markers.Apostolos ZaravinosGeorge I LambrouIoannis BoulalasDimitris DelakasDemetrios A SpandidosPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 4, p e18135 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Apostolos Zaravinos
George I Lambrou
Ioannis Boulalas
Dimitris Delakas
Demetrios A Spandidos
Identification of common differentially expressed genes in urinary bladder cancer.
description <h4>Background</h4>Current diagnosis and treatment of urinary bladder cancer (BC) has shown great progress with the utilization of microarrays.<h4>Purpose</h4>Our goal was to identify common differentially expressed (DE) genes among clinically relevant subclasses of BC using microarrays.<h4>Methodology/principal findings</h4>BC samples and controls, both experimental and publicly available datasets, were analyzed by whole genome microarrays. We grouped the samples according to their histology and defined the DE genes in each sample individually, as well as in each tumor group. A dual analysis strategy was followed. First, experimental samples were analyzed and conclusions were formulated; and second, experimental sets were combined with publicly available microarray datasets and were further analyzed in search of common DE genes. The experimental dataset identified 831 genes that were DE in all tumor samples, simultaneously. Moreover, 33 genes were up-regulated and 85 genes were down-regulated in all 10 BC samples compared to the 5 normal tissues, simultaneously. Hierarchical clustering partitioned tumor groups in accordance to their histology. K-means clustering of all genes and all samples, as well as clustering of tumor groups, presented 49 clusters. K-means clustering of common DE genes in all samples revealed 24 clusters. Genes manifested various differential patterns of expression, based on PCA. YY1 and NFκB were among the most common transcription factors that regulated the expression of the identified DE genes. Chromosome 1 contained 32 DE genes, followed by chromosomes 2 and 11, which contained 25 and 23 DE genes, respectively. Chromosome 21 had the least number of DE genes. GO analysis revealed the prevalence of transport and binding genes in the common down-regulated DE genes; the prevalence of RNA metabolism and processing genes in the up-regulated DE genes; as well as the prevalence of genes responsible for cell communication and signal transduction in the DE genes that were down-regulated in T1-Grade III tumors and up-regulated in T2/T3-Grade III tumors. Combination of samples from all microarray platforms revealed 17 common DE genes, (BMP4, CRYGD, DBH, GJB1, KRT83, MPZ, NHLH1, TACR3, ACTC1, MFAP4, SPARCL1, TAGLN, TPM2, CDC20, LHCGR, TM9SF1 and HCCS) 4 of which participate in numerous pathways.<h4>Conclusions/significance</h4>The identification of the common DE genes among BC samples of different histology can provide further insight into the discovery of new putative markers.
format article
author Apostolos Zaravinos
George I Lambrou
Ioannis Boulalas
Dimitris Delakas
Demetrios A Spandidos
author_facet Apostolos Zaravinos
George I Lambrou
Ioannis Boulalas
Dimitris Delakas
Demetrios A Spandidos
author_sort Apostolos Zaravinos
title Identification of common differentially expressed genes in urinary bladder cancer.
title_short Identification of common differentially expressed genes in urinary bladder cancer.
title_full Identification of common differentially expressed genes in urinary bladder cancer.
title_fullStr Identification of common differentially expressed genes in urinary bladder cancer.
title_full_unstemmed Identification of common differentially expressed genes in urinary bladder cancer.
title_sort identification of common differentially expressed genes in urinary bladder cancer.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/cded9b131f7341ea82571a9e149b8786
work_keys_str_mv AT apostoloszaravinos identificationofcommondifferentiallyexpressedgenesinurinarybladdercancer
AT georgeilambrou identificationofcommondifferentiallyexpressedgenesinurinarybladdercancer
AT ioannisboulalas identificationofcommondifferentiallyexpressedgenesinurinarybladdercancer
AT dimitrisdelakas identificationofcommondifferentiallyexpressedgenesinurinarybladdercancer
AT demetriosaspandidos identificationofcommondifferentiallyexpressedgenesinurinarybladdercancer
_version_ 1718424195690397696